SOST and arthritic joint disease: In a mouse model of antigen (G6PI)-induced, partially TNF-α-dependent arthritis, sclerostin was found to have no effect on bone loss; however, it diminished the disease activity in a TNF-α-independent, serum-derived model in K/BxN mice.